U.S. federal trademark · Serial No. 85287246 · Reg. No. 2564381
Pharmaceuticals for use in stimulating human blood cell production; pharmaceuticals for the treatment of cancer, anemia, renal failure, anoxia-induced cellular degeneration, and hypoxia-induced cellular degeneration
Source: USPTO federal trademark records. Informational only, not legal advice. Status and details may lag the live USPTO database.